L. Patients-ont-bénéficié-de-la-chimiothérapie-intra-artérielle-du-fait-d, une absence de réponse clinique et/ou radiologique associée le plus souvent à une mauvaise tolérance hématologique des chimiothérapies conventionnelles par voie intraveineuse. L'état général des patients était bon avant l'initiation de la chimiothérapie intra-artérielle. La tolérance de la chimiothérapie intra-artérielle a été globalement bonne sur le plan hématologique (cf. Tableau XI) Un patient a présenté une aplasie et un autre une toxicité cardiaque, aucun n'a gardé de séquelles. La procédure en elle-même n'a pas engendré de toxicité, preuve qu'elle est bien maitrisée

G. Dutertre, K. Hoang-xuan, and D. Ricard, Tumeurs intracr??niennes de l'adulte, EMC - Trait?? de m??decine AKOS, vol.5, issue.2, pp.5-1001, 2010.
DOI : 10.1016/S1634-6939(10)52309-3

A. Belot, P. Grosclaude, and N. Bossard, Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique, pp.159-75, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00338335

D. Reizine, J. Guichard, and G. Jourdan, Radiodiagnostic -Squelette normal -Neuroradiologie-Appareil locomoteur, pp.31-660, 2006.

F. Elsevier-masson, Revue neurologique, Mai, vol.165, pp.863-74, 2009.

M. Brightman and Y. Kadota, Nonpermeable and permeable vessels of the brain, NIDA Res monogr, vol.120, pp.87-107, 1992.
DOI : 10.1037/e496142006-009

M. Petty and E. Lo, Junctional complexes of the blood???brain barrier: permeability changes in neuroinflammation, Progress in Neurobiology, vol.68, issue.5, pp.311-334, 2002.
DOI : 10.1016/S0301-0082(02)00128-4

D. Abrahamson, Recent studies on the structure and pathology of basement membranes, The Journal of Pathology, vol.797, issue.4
DOI : 10.1016/0304-4165(84)90384-2

T. Berzin, B. Zipser, and M. Rafii, Agrin and microvascular damage in Alzheimer???s disease, Neurobiology of Aging, vol.21, issue.2, pp.349-55, 2000.
DOI : 10.1016/S0197-4580(00)00121-4

S. Lee, J. Kim, and Y. Choi, SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier, Nature Medicine, vol.7, issue.7, pp.900-906, 2003.
DOI : 10.1038/86507

K. Wosik, R. Cayrol, and A. Dodelet-devillers, Angiotensin II Controls Occludin Function and Is Required for Blood Brain Barrier Maintenance: Relevance to Multiple Sclerosis, Journal of Neuroscience, vol.27, issue.34, pp.9032-9074, 2007.
DOI : 10.1523/JNEUROSCI.2088-07.2007

H. Wolburg and A. Lippoldt, Tight junctions of the blood???brain barrier, Vascular Pharmacology, vol.38, issue.6, pp.323-360, 2002.
DOI : 10.1016/S1537-1891(02)00200-8

W. Loscher and H. Potschka, Drug resistance in brain diseases and the role of drug efflux transporters, Nature Reviews Neuroscience, vol.5, issue.Suppl. 1, pp.591-602, 2005.
DOI : 10.2174/1389200043489199

D. Lange and E. , Potential role of ABC transporters as a detoxification system at the blood- CSF barrier, Adv Drug Deliv Rev, vol.56, pp.1793-809, 2004.

A. Tsuji, Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems, NeuroRX, vol.1359, issue.1193, pp.54-62, 2005.
DOI : 10.1016/S0167-4889(97)00096-7

L. Roberts, D. Black, and C. Raman, Subcellular localization of transporters along the rat blood???brain barrier and blood???cerebral-spinal fluid barrier by in vivo biotinylation, Neuroscience, vol.155, issue.2
DOI : 10.1016/j.neuroscience.2008.06.015

M. Nicholas, Glioblastome multiforme: evidence-based approach to therapy. Expert rev anticancer, pp.23-30, 2007.

S. Rapoport, M. Hori, and I. Klatzo, Testing of a hypothesis for osmotic opening of the bloodbrain barrier, Am J Physiol, vol.223, pp.323-354, 1972.

F. David, La barrière hémato-encéphalique : un facteur clé en Neuro-oncologie, Rev Neurol. Mai, vol.160, issue.5, pp.523-555, 2004.

D. Fortin and E. Neuwelt, Therapeutic manipulation of the blood-brain barrier. Neurobaseneurosurgery . First edition, Medlink CD-ROM, 2003.

D. Emerich, P. Snodgrass, and R. Dean, Enhanced delivery of carboplatin into brain tumours with intravenous CereportTM (RMP-7): dramatic differences and insight gained from dosing parameters, British Journal of Cancer, vol.80, issue.7, pp.964-70, 1999.
DOI : 10.1038/sj.bjc.6690450

K. Warren, R. Jakacki, and B. Widemann, Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children???s Oncology Group, Cancer Chemotherapy and Pharmacology, vol.48, issue.3, pp.343-350, 2006.
DOI : 10.1007/s00280-005-0172-7

M. Prados, S. Schold, . Sc, and H. Fine, A randomised, double-blind, placebocontrolled , phase 2 study of RMP-7 in combinaison with carboplatin administered intravenously for the treatment of malignant glioma. Neuro-oncol, pp.96-103, 2003.

J. Deeken and W. Löscher, The blood-brain barrier and cancer. Clin Cancer Res, 2007.

S. Fellner, B. Bauer, and D. Miller, Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo, Journal of Clinical Investigation, vol.110, issue.9, pp.1309-1327, 2002.
DOI : 10.1172/JCI0215451

T. Visted, P. Enger, and M. Lund-johansen, Mechanisms of tumor cell invasion and angiogenesis in the central nervous system, front Biosci, vol.8, pp.289-304, 20031.

N. Weiss, F. Miller, and S. Cazaubon, Implication de la barrière hémato-encéphalique dans la physiopathologie des maladies neurologiques: Partie II. Revue neurol, pp.1010-1032, 2009.
DOI : 10.1016/j.neurol.2009.04.013

H. Wolburg, K. Wolburg-buchholz, and J. Kraus, Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme, Acta Neuropathol, 2003.

M. Papadopoulos, S. Saadoun, and C. Woodrow, Occludin expression in microvessels of neoplastic and non-neoplastic human brain, Neuropathology and Applied Neurobiology, vol.129, issue.5, pp.384-95, 2001.
DOI : 10.1083/jcb.120.2.477

J. Gallo, S. Li, and P. Guo, The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice. Cancer research, pp.5114-5121, 2003.

S. Fellner, B. Bauer, and D. Miller, Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo, Journal of Clinical Investigation, vol.110, issue.9, pp.1309-1318, 2002.
DOI : 10.1172/JCI0215451

F. Bouculat, P. Chabrot, and A. Léger-enreille, Pharmacocinétique du cisplatine : comparaison expérimentale de la voie intra-artérielle hépatique et de la voie veineuse systémique chez le porc. Gastroenterologie clinique et biologique, Mars, vol.33, issue.HS1, p.153, 2009.
DOI : 10.1016/s0399-8320(09)72901-x

E. Neuwelt, P. Barnett, and C. Mccormick, Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologicaly diverse agents. Clin Cancer Res, pp.1549-55, 1998.

R. Blasberg, G. Groothuis, and P. Molnar, A review of hyperosmotic blood-brain barrier disruption in seven experimental brain tumors models, Pathophysiology of the blood-brain barrier, pp.197-220, 1990.

E. Neuwelt, P. Barnett, and C. Mccormick, Differential Permeability of Human Brain Tumor Xenograft in the nude rat: Impact of size tumor and Method of Administration on optmizing delivery of biologically diverse agent. Clinical Cancer Research, pp.1549-55, 1998.

K. Yamada, Y. Ushio, and T. Hayakawa, Distribution of radiolabeled 1-(4-Amino-2-methyl-5- pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride in rat brain tumor: intraarterial versus intravenous administration, Cancer Res, vol.7, issue.8, pp.2123-2151, 1987.

D. Bullard, S. Bigner, and D. Bigner, Comparison of intravenous versus intracarotid therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea in a rat brain tumor model, Cancer Res

A. Weyerbrock, S. Walbridge, and M. Pluta, Selective opening of the blood tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas, J. neurosurg, 2003.

K. Jahnke, D. Kraemer, and K. Knight, Intraarterial chemotherapy and osmotic bloodbrain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system. Cancer, Feb, vol.1, issue.1123, pp.581-589, 2008.

D. Fortin, A. Desjardins, and A. Benko, Enhanced Chemotherapy delivery by intraarterial infusion and blood brain barrier disruption in malignant brain tumors The Sherbrook Experience. Cancer, Jun, vol.15103, issue.12, pp.20606-20621, 2005.

D. Fortin, C. Gendron, and M. Boudrias, Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis, Cancer, vol.8, issue.4
DOI : 10.1001/archneur.1996.00550080140022

D. Stewart, S. Wallace, and L. Feun, A phase I study of intracarotid Artery infusion of cisdiamminedichloroplatinum(II ) in patients with recurrent malignant intracerebral tumors

H. Newton, M. Slivka, and C. Volpi, Intra-arterial carboplatin and intraveinous etoposide for the treatment of metastatic brain tumors, Journal of Neuro-Oncology, vol.61, issue.1, pp.35-44, 2003.
DOI : 10.1023/A:1021218207015

F. Shimizu and M. Arakawa, Effect of 1-(4-amino-2-methyl-5-pyrimidinyl), p.3

H. Hasegawa, W. Shapiro, and J. Posner, Effect of ACNU on experimental brain tumor, Cancer Res, vol.39, issue.7, pp.2687-90, 1979.

N. Roosen, J. Kiwit, and E. Lins, Adjuvant intraarterial chemotherapy with nimustine in the management of World Health Organization Grade IV gliomas of the brain, pp.1984-94, 1989.

E. Bourekas, H. Newton, and G. Figg, Prevalence and rupture rate of cerebral aneuvrisms discovered during intra-arterial chemotherapy of brain tumors, AJNR Am J

J. King, Epidemiology of aneurysmal subarachnoid hemorrhage, Neuroimaging Clin N

W. Schievink, Intracranial Aneurysms, New England Journal of Medicine, vol.336, issue.1, pp.28-40, 1997.
DOI : 10.1056/NEJM199701023360106

K. Panageas, E. Elkin, and L. Deangelis, Trends in survival from primary central nervous system lymphoma, 1975-1999, Cancer, vol.103, issue.11, pp.2466-72, 2005.
DOI : 10.7326/0003-4819-129-12-199812150-00005